Pulmonary embolism overview: Difference between revisions

Jump to navigation Jump to search
m (New page: {{Pulmonary embolism}} {{CMG}} '''Associate Editors-in-Chief:''' Ujjwal Rastogi, MBBS [mailto:urastogi@perfuse.org] '''''Synonyms and keywords:''''' PE ==Ov...)
 
No edit summary
Line 11: Line 11:
'''Synonyms and Associated Terms:''' PE
'''Synonyms and Associated Terms:''' PE


'''Pulmonary embolism''' (PE) is a common illness that can cause death and significant disability. PE occurs when there is an acute obstruction of the [[pulmonary artery]] (or one of its branches). Most often this is due to a [[vein|venous]] [[thrombus]] (blood clot from a vein), which has been dislodged from its site of formation and [[embolism|embolizes]] to the [[pulmonary artery|arterial]] blood supply of one of the lungs. This process is termed ''[[thromboembolism]]''.
'''Pulmonary embolism''' (PE) is a potentially lethal condition. PE occurs when there is an acute obstruction of the [[pulmonary artery]] (or one of its branches). Most often this is due to a [[vein|venous]] [[thrombus]] (blood clot from a vein), which has been dislodged from its site of formation and [[embolism|embolizes]] to the [[pulmonary artery|arterial]] blood supply of one of the lungs. This process is termed ''[[thromboembolism]]''.


Patients present with a wide array of symptoms and signs. These may include [[dyspnea|difficulty breathing]], [[Pain and nociception|pain]] [[chest pain|in the chest]] during breathing, and in more severe cases [[Collapse (medical)|collapse]], [[Shock (medical)|circulatory instability]] and [[cardiac arrest|sudden death]]. PE treatment requires rapid and accurate risk stratification before haemodynamic decompensation and the development of cardiogenic shock. Therapeutic application most often consists of an [[anticoagulant]] medication, such as [[heparin]] and [[warfarin]], and rarely (in severe cases) with [[thrombolysis]] or surgery. In other, rarer forms of pulmonary embolism, material other than a blood clot is responsible; this may include [[Lipid|fat]] or [[bone]] (usually in association with significant trauma), air (often when diving), clumped [[tumor cell]]s, and [[amniotic fluid]] (affecting mothers during [[childbirth]]).
Patients present with a wide array of symptoms and signs. These may include [[dyspnea|difficulty breathing]], [[Pain and nociception|pain]] [[chest pain|in the chest]] during breathing, and in more severe cases [[Collapse (medical)|collapse]], [[Shock (medical)|circulatory instability]] and [[cardiac arrest|sudden death]]. PE treatment requires rapid and accurate risk stratification before haemodynamic decompensation and the development of cardiogenic shock. Therapeutic application most often consists of an [[anticoagulant]] medication, such as [[heparin]] and [[warfarin]], and rarely (in severe cases) with [[thrombolysis]] or surgery. In other, rarer forms of pulmonary embolism, material other than a blood clot is responsible; this may include [[Lipid|fat]] or [[bone]] (usually in association with significant trauma), air (often when diving), clumped [[tumor cell]]s, and [[amniotic fluid]] (affecting mothers during [[childbirth]]).

Revision as of 17:17, 21 July 2011

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism overview

CDC on Pulmonary embolism overview

Pulmonary embolism overview in the news

Blogs on Pulmonary embolism overview

Directions to Hospitals Treating Pulmonary embolism overview

Risk calculators and risk factors for Pulmonary embolism overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]

Synonyms and keywords: PE

Overview

Synonyms and Associated Terms: PE

Pulmonary embolism (PE) is a potentially lethal condition. PE occurs when there is an acute obstruction of the pulmonary artery (or one of its branches). Most often this is due to a venous thrombus (blood clot from a vein), which has been dislodged from its site of formation and embolizes to the arterial blood supply of one of the lungs. This process is termed thromboembolism.

Patients present with a wide array of symptoms and signs. These may include difficulty breathing, pain in the chest during breathing, and in more severe cases collapse, circulatory instability and sudden death. PE treatment requires rapid and accurate risk stratification before haemodynamic decompensation and the development of cardiogenic shock. Therapeutic application most often consists of an anticoagulant medication, such as heparin and warfarin, and rarely (in severe cases) with thrombolysis or surgery. In other, rarer forms of pulmonary embolism, material other than a blood clot is responsible; this may include fat or bone (usually in association with significant trauma), air (often when diving), clumped tumor cells, and amniotic fluid (affecting mothers during childbirth).

References

Template:WH Template:WS